semaglutide for office use of new diet drugs likely to mushroom— Harvard Gazette McKee's proposed FY2027 budget drops

A 2024 retrospective cohort analysis published in Diabetes, Obesity and Metabolism (N=312 patients who switched from semaglutide to tirzepatide at a single academic center) found that switchers lost an additional mean of 6.3% of body weight over 6 months after the switch, with 68% reporting either stable or improved GI tolerability [12]

Comprehensive analysis of expression and prognostic value of selenoprotein genes in thyroid cancer

Its more medically complex than general weight counseling and requires coordination with prescribing providers

No fancy lingo, just the facts and a little chit-chat about what this thing is, how it might lend a hand with weight loss, and what to keep in mind